Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.
Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH; Second International Symposium on IgG4-Related Disease. Khosroshahi A, et al. Among authors: witzig te. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132. Arthritis Rheumatol. 2015. PMID: 25809420 Review. No abstract available.
Rituximab for IgG4-related disease: a prospective, open-label trial.
Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S, Stone JH. Carruthers MN, et al. Among authors: witzig te. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605. Epub 2015 Feb 9. Ann Rheum Dis. 2015. PMID: 25667206
Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.
Stone JH, Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S. Stone JH, et al. Among authors: witzig te. Ann Rheum Dis. 2015 Aug;74(8):e47. doi: 10.1136/annrheumdis-2015-207640. Epub 2015 Apr 28. Ann Rheum Dis. 2015. PMID: 26160908 No abstract available.
Asthma and orbital immunoglobulin G4-related disease.
Baqir M, Garrity JA, Vassallo R, Witzig TE, Ryu JH. Baqir M, et al. Among authors: witzig te. Ann Allergy Asthma Immunol. 2016 Apr;116(4):313-6. doi: 10.1016/j.anai.2015.12.003. Epub 2016 Jan 9. Ann Allergy Asthma Immunol. 2016. PMID: 26782673
Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
Majumder S, Mohapatra S, Lennon RJ, Piovezani Ramos G, Postier N, Gleeson FC, Levy MJ, Pearson RK, Petersen BT, Vege SS, Chari ST, Topazian MD, Witzig TE. Majumder S, et al. Among authors: witzig te. Clin Gastroenterol Hepatol. 2018 Dec;16(12):1947-1953. doi: 10.1016/j.cgh.2018.02.049. Epub 2018 Mar 8. Clin Gastroenterol Hepatol. 2018. PMID: 29526692
Gamma-heavy chain disease: review of 23 cases.
Wahner-Roedler DL, Witzig TE, Loehrer LL, Kyle RA. Wahner-Roedler DL, et al. Among authors: witzig te. Medicine (Baltimore). 2003 Jul;82(4):236-50. doi: 10.1097/01.md.0000085058.63483.7f. Medicine (Baltimore). 2003. PMID: 12861101 Free article.
Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Nowakowski GS, Witzig TE. Nowakowski GS, et al. Among authors: witzig te. Clin Adv Hematol Oncol. 2006 Mar;4(3):225-31. Clin Adv Hematol Oncol. 2006. PMID: 16728934 Review.
628 results